Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD


Primary Symbol: V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by pirateinvestoron Jan 04, 2022 10:30pm
107 Views
Post# 34283937

RE:Questions about submissions

RE:Questions about submissionsKaidog.. I was thinking the same things about the RALI-DX Health Canada Q4 2021 and the Exact Antibody Test for EUA FDA submission for approval.   I have not seen any news about this at all..  In the presentation is says the RALI-DX was submitted to Health Canada..   Searching on the Internet does not bring up any news on these topics.   

With the new COVID spikes I am sure emergency departments around the world would like RALI-DX to identify who can go home and who needs to stay at the hospital.  

I've been invested in SQI for one year now and SQI Board and Mgt have kept their cards close and haven't shared the story yet but I hope in early 2022 we get some real PR to get things moving in the SQI stock price.  We all complain about it here all of the time.

My reflection on 2021 is SQI aligned themselves for commercialization and ensuring the key people are rewarded for their efforts.  The insiders kept on investing into the company in R&D, manufacturings etc.

I'm sure the three insiders are in the business of winning and we need to be patient in the process.

PR
<< Previous
Bullboard Posts
Next >>